Clinical Trials Logo

Clinical Trial Summary

Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03328143
Study type Interventional
Source Aurora Health Care
Contact Gary Dennison, CIP
Phone 414-385-1913
Email gary.dennison@aurora.org
Status Recruiting
Phase Phase 1
Start date April 3, 2018
Completion date February 7, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03212976 - Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure N/A
Withdrawn NCT04946435 - Topical Antibiotic Prophylaxis for Nasal Packing Post-ESBS Phase 1
Terminated NCT02388880 - Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion (4hour) N/A
Terminated NCT01824576 - Effect of Intrathoracic Pressure Regulation on Decreased Cerebral Perfusion N/A